Witnessing the stock’s movement on the chart, on Wednesday, Dexcom Inc (NASDAQ: DXCM) had a quiet start as it plunged -2.91% to $83.87, before settling in for the price of $86.38 at the close. Taking a more long-term approach, DXCM posted a 52-week range of $62.34-$142.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 25.24%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.95%. This publicly-traded company’s shares outstanding now amounts to $390.60 million, simultaneously with a float of $385.55 million. The organization now has a market capitalization sitting at $32.76 billion. At the time of writing, stock’s 50-day Moving Average stood at $82.04, while the 200-day Moving Average is $88.68.
Dexcom Inc (DXCM) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Dexcom Inc’s current insider ownership accounts for 1.29%, in contrast to 94.58% institutional ownership. According to the most recent insider trade that took place on Jan 29 ’25, this organization’s EVP, Chief Financal Officer sold 2,090 shares at the rate of 86.91, making the entire transaction reach 181,650 in total value, affecting insider ownership by 83,526. Preceding that transaction, on Jan 29 ’25, Company’s EVP, Strategy & Corporate Dev sold 1,183 for 86.91, making the whole transaction’s value amount to 102,820. This particular insider is now the holder of 42,044 in total.
Dexcom Inc (DXCM) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.38 per share during the current fiscal year.
Dexcom Inc’s EPS increase for this current 12-month fiscal period is 10.95% and is forecasted to reach 2.02 in the upcoming year.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Let’s observe the current performance indicators for Dexcom Inc (DXCM). It’s Quick Ratio in the last reported quarter now stands at 2.12. The Stock has managed to achieve an average true range (ATR) of 2.38. Alongside those numbers, its PE Ratio stands at $50.28, and its Beta score is 1.30. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.29. Similarly, its price to free cash flow for trailing twelve months is now 61.23.
In the same vein, DXCM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.67, a figure that is expected to reach 0.50 in the next quarter, and analysts are predicting that it will be 2.02 at the market close of one year from today.
Technical Analysis of Dexcom Inc (DXCM)
Going through the that latest performance of [Dexcom Inc, DXCM]. Its last 5-days volume of 3.02 million was inferior to the volume of 3.32 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 34.36% While, its Average True Range was 2.28.
Raw Stochastic average of Dexcom Inc (DXCM) in the period of the previous 100 days is set at 76.96%, which indicates a major rise in contrast to 1.55% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 21.79% that was lower than 31.90% volatility it exhibited in the past 100-days period.
